← Open Payments lookup

SARA DONNELLY: Open Payments

NPI 1760761449 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,696 in 77 payments from 16 companies in 2025. Trend: 2023 $1,631 · 2024 $2,491 · 2025 $1,696

Food & beverage: $1,696
CompanyPaymentsAmount
Gilead Sciences, Inc.7$248
Madrigal Pharmaceuticals10$203
ABBVIE INC.13$202
Celltrion USA Inc.9$145
Intercept Pharmaceuticals, Inc.7$135
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$128
Regeneron Healthcare Solutions, Inc.4$106
Takeda Pharmaceuticals U.S.A., Inc.3$102
Ipsen Biopharmaceuticals, Inc4$86
AstraZeneca Pharmaceuticals LP3$81

Products named: REZDIFFRA, VEGZELMA, DUPIXENT, OCALIVA, XIFAXAN, ENTYVIO, LINZESS, IQIRVO.

Industry payments across CA — which companies pay providers there.